Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. For this reason, it is recommended that adolescents, both
Vaccines that protect adolescent girls and women from the human papillomavirus (HPV) and from developing cervical cancer may also help prevent oropharyngeal cancers. Worldwide the incidence of oropharyngeal cancer
Millions of women worldwide have been tested for cervical cancer, human papillomavirus (HPV) and other problems via the PAP test. The procedure was invented in 1943 by Dr. George Papanicolaou (thus the name), and has become the most widely used cancer-screening test in the world
Human papillomavirus (HPV) is a leading cause of cervical cancer in women and genital warts in both sexes. Fortunately, these ills can now be prevented by a series of vaccinations that are typically given before a boy or girl becomes sexually active.
Two pieces of good news regarding protecting from, and detecting early, cervical cancer caused by HPV: one dose of vaccine may work as well as the recommended three; and screening cervical cells for HPV may be more predictive of dangerous infection than the Pap smear.
According to a survey published this month in the American Journal of Preventive Medicine, less than one third of obstetrician-gynecologists give eligible patients the HPV vaccine and only half adhere to the guidelines published in 2009. These guidelines recommend vaccinating women ages 11 26 years, a recommendation that has been in effect since 2006. In 2009, the American Congress of Obstetricians and Gynecologists (ACOG) added additional guidelines recommending biannual Pap tests for women between the ages of 21 and 29.